Enhancing molecular and genomic approaches for Bordetella pertussis investigation and public health surveillance in Victoria, Australia
- 1The University of Melbourne
Abstract
Bordetella pertussis is the main aetiological agent of pertussis (whooping cough), with a global resurgence of cases reported in 2024. As current pertussis diagnostics are predominantly based on molecular methods, cultured isolates are increasingly scarce, limiting traditional culture-based surveillance. To address these challenges, this study evaluated culture-independent approaches for B. pertussis surveillance and their feasibility for implementation in public health laboratory settings in Victoria, Australia. The Microbiological Diagnostic Unit Public Health Laboratory received 356 nasopharyngeal clinical specimens that were PCR-positive for Bordetella spp. from diagnostic laboratories for further characterisation during the 2024-2025 epidemic period. Culture-based approaches yielded only five B. pertussis isolates, largely due to limitations associated with specimen transport media. Four culture-independent approaches were evaluated for B. pertussis characterisation: real-time PCR assay for high-resolution Bordetella spp. differentiation (n=356), multiplex PCR amplicon sequencing assay for lineage typing (n=38), in-house laboratory developed test implemented on Panther Fusion(R) System for macrolide resistance screening (n=92) and shotgun metagenomic sequencing (n=5). The dataset was dominated by B. pertussis (330/356; 92.7%) with most strains harbouring ptxP3 (35/38; 92.1%) allele and the macrolide resistance rate was reported as 4.3% (4/92). Shotgun metagenomics was able to detect B. pertussis directly from clinical samples, but the genomic recovery was limited. Evaluation of operational performance and workflow integration highlighted method-specific strengths and limitations, informing suitability for implementation in public health laboratories. This study demonstrates the potential to integrate culture-independent approaches into public health laboratory settings to strengthen B. pertussis surveillance and inform feasible workflow design amid limited culture availability.
Importance statementCulture-independent approaches are increasingly valuable for Bordetella pertussis investigations and surveillance, particularly as declining culture recovery limits the availability of isolates for downstream characterisation. The emergence and dissemination of vaccine-evading and macrolide-resistant B. pertussis strains highlight the need for robust laboratory strategies to support continuous surveillance and enhance preparedness for future pertussis epidemics. This study evaluates four culture- independent molecular and genomic approaches for B. pertussis, including species detection and differentiation, macrolide resistance screening and lineage typing while assessing their operational characteristics and feasibility for implementation in public health laboratory settings. These findings provide insights into the potential role of integrated workflows in strengthening B. pertussis surveillance and public health investigations.
Data summaryGenome sequences of Bordetella pertussis isolates are deposited in GenBank under BioProject PRJNA870170. Sample data and accession numbers are included in the Supplementary Table S1. The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files.
Related
- Epidemiological investigation of Shuni virus infections in hospitals in two provinces of South Africa (2019–2021) using molecular and serological surveillance
- Enhancing global health security through tele-mentoring: a descriptive case study of the public health surveillance ECHO in Uganda
- Signal detection of substance-related emergency department visits during UEFA EURO 2024 in Germany: enhancing public health surveillance for future mass gatherings.
- Editorial: Decoding cancer complexity with artificial intelligence and molecular level studies: informatics-driven approaches for therapeutic innovation
- Paediatric mpox during Sierra Leone’s 2024 to 2025 clade IIb outbreak: A national surveillance and outbreak-investigation study of 415 children
BibTeX
@misc{kumar2026enhancing,
title = {{Enhancing molecular and genomic approaches for Bordetella pertussis investigation and public health surveillance in Victoria, Australia}},
author = {L. Sadeesh Kumar and M. Sait and M. Fachrul and L. M. Judd and J. A. Lacey and J. Strachan and S. L. Baines and B. P. Howden and N. L. Sherry},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.11.26364704},
url = {https://www.medrxiv.org/content/10.64898/2026.10.11.26364704v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Enhancing molecular and genomic approaches for Bordetella pertussis investigation and public health surveillance in Victoria, Australia
AU - L. Sadeesh Kumar
AU - M. Sait
AU - M. Fachrul
AU - L. M. Judd
AU - J. A. Lacey
AU - J. Strachan
AU - S. L. Baines
AU - B. P. Howden
AU - N. L. Sherry
PY - 2026
DA - 2026/10/11
PB - medRxiv
DO - 10.64898/2026.10.11.26364704
UR - https://www.medrxiv.org/content/10.64898/2026.10.11.26364704v1
AB - Bordetella pertussis is the main aetiological agent of pertussis (whooping cough), with a global resurgence of cases reported in 2024. As current pertussis diagnostics are predominantly based on molecular methods, cultured isolates are increasingly scarce, limiting traditional culture-based surveillance. To address these challenges, this study evaluated culture-independent approaches for B. pertussis surveillance and their feasibility for implementation in public health laboratory settings in Victoria, Australia. The Microbiological Diagnostic Unit Public Health Laboratory received 356 nasopharyngeal clinical specimens that were PCR-positive for Bordetella spp. from diagnostic laboratories for further characterisation during the 2024-2025 epidemic period. Culture-based approaches yielded only five B. pertussis isolates, largely due to limitations associated with specimen transport media. Four culture-independent approaches were evaluated for B. pertussis characterisation: real-time PCR assay for high-resolution Bordetella spp. differentiation (n=356), multiplex PCR amplicon sequencing assay for lineage typing (n=38), in-house laboratory developed test implemented on Panther Fusion(R) System for macrolide resistance screening (n=92) and shotgun metagenomic sequencing (n=5). The dataset was dominated by B. pertussis (330/356; 92.7%) with most strains harbouring ptxP3 (35/38; 92.1%) allele and the macrolide resistance rate was reported as 4.3% (4/92). Shotgun metagenomics was able to detect B. pertussis directly from clinical samples, but the genomic recovery was limited. Evaluation of operational performance and workflow integration highlighted method-specific strengths and limitations, informing suitability for implementation in public health laboratories. This study demonstrates the potential to integrate culture-independent approaches into public health laboratory settings to strengthen B. pertussis surveillance and inform feasible workflow design amid limited culture availability. Importance statementCulture-independent approaches are increasingly valuable for Bordetella pertussis investigations and surveillance, particularly as declining culture recovery limits the availability of isolates for downstream characterisation. The emergence and dissemination of vaccine-evading and macrolide-resistant B. pertussis strains highlight the need for robust laboratory strategies to support continuous surveillance and enhance preparedness for future pertussis epidemics. This study evaluates four culture- independent molecular and genomic approaches for B. pertussis, including species detection and differentiation, macrolide resistance screening and lineage typing while assessing their operational characteristics and feasibility for implementation in public health laboratory settings. These findings provide insights into the potential role of integrated workflows in strengthening B. pertussis surveillance and public health investigations. Data summaryGenome sequences of Bordetella pertussis isolates are deposited in GenBank under BioProject PRJNA870170. Sample data and accession numbers are included in the Supplementary Table S1. The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files.
ER -